Prevention of hospital-acquired pneumonia:: European perspective

Infectious Disease Clinics of North America

Volumn 17, Issue 4, 2003, Pages 773-784

  Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFOTAXIME; CEFOXITIN; CHLORHEXIDINE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; OFLOXACIN; PENICILLIN G; RANITIDINE; SUCRALFATE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVICE INFECTION; ENTERIC FEEDING; EUROPE; FEASIBILITY STUDY; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; LUNG ASPIRATION; LUNG INFECTION; META ANALYSIS; PATHOGENESIS; PNEUMONIA; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STRESS ULCER; SUPINE POSITION; TOPICAL TREATMENT; VENTILATOR; WOUND DRAINAGE;

EID: 1042266301     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(03)00068-0     Document Type: Review

References (57)

1. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med. 153:1996;1711-1725.
2. Tablan O.C., Anderson L.J., Arden N.H., et al. Guideline for prevention of nosocomial pneumonia Part I. Issues on prevention of nosocomial pneumonia, 1994 . Infect Control Hosp Epidemiol. 15:1994;588-627.
3. Collard H.R., Saint S., Matthay M.A. Prevention of ventilator-associated pneumonia: an evidence-based systematic review. Ann Intern Med. 138:2003;494-501.
4. van der Waaij D., Berghuis-de Vries J.M., Lekkerkerk-van der Wees J.E.C. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hygiene. 69:1971;405-411.
5. Stoutenbeek C.P., van Saene H.K.F., Miranda D.R., Zandstra D.F. The effect of selective decontamination of the digestive tract on colonization and infection rate in multiple trauma patients. Intensive Care Med. 10:1984;185-192.
6. Bonten M.J.M., Kullberg B.J., Dalen R.V., et al. Selective digestive decontamination in patients in intensive care. J Antimicrob Chemother. 46:2000;351-362.
7. D'Amico R., Pifferi S., Leonetti C., Torri V., Tinazzi A., Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systemic review of randomised controlled trials. BMJ. 316:1998;1275-1285.
8. Nathens A.B., Marshall J.C. Selective decontamination of the digestive tract in surgical patients: a systemic review of the evidence. Arch Surg. 134:1999;170-176.
9. Kollef M.H. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest. 105:1994;1101-1108.
10. Heyland D.K., Cook D.J., Jaeschke R., Griffith L., Lee H.N., Guyatt G.H. Selective decontamination of the digestive tract: an overview. Chest. 105:1994;1221-1229.
11. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. BMJ. 307:1993;525-532.
12. Vandenbroucke-Grauls C.M.J.E., Vandenbroucke J.P. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 338:1991;859-862.
13. van Nieuwenhoven C.A., Buskens E., van Tiel F.H., Bonten M.J. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients. JAMA. 286:2001;335-340.
14. Hurley J.C. Prophylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection? Antimicrob Agents Chemother. 39:1995;941-947.
15. Krueger W.A., Lenhart F.P., Neeser G., et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med. 166:2002;1029-1037.
16. de Jonge E., Schultz M., Spanjaard L., et al. Effects of selective decontamination of the digestive tract on mortality and antibiotic resistance. [abstract] Intensive Care Med. 28:2002;S12.
17. Lingnau W., Berger J., Javorsky F., Fille M., Allerberger F., Benzer H. Changing bacterial ecology during a five year period of selective intestinal decontamination. J Hosp Infect. 39:1998;195-206.
18. Misset B., Kitzis M.D., Mahe P., et al. Bacteriological side effects of gut decontamination with polymyxin E, gentamicin, and amphotericin B. Infect Control Hosp Epidemiol. 14:1993;62-64.
19. Misset B., Kitzis M.D., Conscience G., Goldstein F.W., Fourrier A., Carlet J. Mechanisms of failure to decontaminate the gut with polymixin E, gentamycin and amphotericin B in patients in intensive care. Eur J Clin Microbiol Infect Dis. 13:1994;165-170.
20. Chang S., Sievert D.M., Hageman J.C., et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 348:2003;1342-1347.
21. Lepper M.H., Kofman S., Blatt N. Effect of eight antibiotics used singly and in combination on the tracheal flora following tracheostomy in poliomyelitis. Antibiot Chemother. 4:1954;829-843.
22. Petersdorf R.G., Curtin J.A., Hoeprich P.D. A study of antibiotic prophylaxis in unconscious patients. N Engl J Med. 257:1957;1001-1009.
23. Petersdorf R.G., Merchant R.K. A study of antibiotic prophylaxis in patients with acute heart failure. N Engl J Med. 260:1959;565-575.
24. Mandelli M., Mosconi P., Langer M., Cigada M. Prevention of pneumonia in an intensive care unit: a randomized multicenter clinical trial. Crit Care Med. 17:1989;501-505.
25. Sirvent J.M., Torres A., El-Ebiary M., Castro P., de Batlle J., Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med. 155:1997;1729-1734.
26. Nouira S., Marghli S., Belghith M., Besbes L., Elatrous S., Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet. 358:2001;2020-2025.
27. Johanson W.G., Pierce A.K., Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients. N Engl J Med. 281:1969;1137-1140.
28. Johanson W.G. Jr., Pierce A.K., Sanford J.P., Thomas G.D. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 77:1972;701-706.
29. Tryba M. The gastropulmonary route of infection: fact or fiction? Am J Med. 91:(suppl 2A):1991;135S-146S.
30. Bonten M.J.M., Gaillard C.A., de Leeuw P.W., Stobberingh E.E. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 24:1997;309-319.
31. Pugin J., Auckenthaler R., Lew D.P., Suter P.M. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia: a randomized, placebo-controlled, double- blind clinical trial. JAMA. 265:1991;2704-2710.
32. Rodriguez-Roldan J.M., Altuna-Cuesta A., Lopez A., et al. Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med. 18:1990;1239-1242.
33. Bergmans D.C., Bonten M.J., Gaillard C.A., et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 164:2001;382-388.
34. Abele-Horn M., Dauber A., Bauernfeind A., et al. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination. Intensive Care Med. 23:1996;187-195.
35. DeRiso A.J. II, Ladowski J.S., Dillon T.A., Justice J.W., Peterson A.C. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 109:1996;1556-1561.
36. Prod'hom G., Leuenberger P., Koerfer J., et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomised controlled trial. Ann Intern Med. 120:1994;653-662.
37. Driks M.R., Craven D.E., Celli B.R., et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonisation. N Engl J Med. 317:1987;1376-1382.
38. Bonten M.J.M., Gaillard C.A., van der Geest S., et al. The role of intragastric acidity and stress ulcer prophylaxis on colonization and infection in mechanically ventilated patients: a stratified, randomized, double blind study of sucralfate versus antacids. Am J Respir Crit Care Med. 152:1995;1825-1834.
39. Cook D., Guyatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 338:1998;791-797.
40. Messori A., Trippoli S., Vaiani M., Corrado A. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 321:2000;1-7.
41. Pingleton S.K., Hinthorn D.R., Liu C. Enteral nutrition in patients receiving mechanical ventilation. Am J Med. 80:1986;827-832.
42. Lee B., Chang R.W.S., Jacobs S. Intermittent nasogastric feeding: a simple and effective method to reduce pneumonia among ventilated ICU patients. Clin Intensive Care. 1:1990;100-102.
43. Skiest D.J., Khan N., Feld R., Metersky M.L. The role of enteral feeding in gastric colonisation: a randomised controlled trial comparing continuous to intermittent enteral feeding in mechanically ventilated patients. Clin Intensive Care. 7:1996;138-143.
44. Bonten M.J.M., Gaillard C.A., van der Hulst R., et al. Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients. Am J Respir Crit Care Med. 154:1996;394-399.
45. Heyland D.K., Drover J.W., MacDonald S., Novak F., Lam M. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: results of a randomized controlled trial. Crit Care Med. 29:2001;1495-1501.
46. Esparza J., Boivin M.A., Hartshorne M.F., Levy H. Equal aspiration rates in gastrically and transpylorically fed critically ill patients. Intensive Care Med. 27:2001;660-664.
47. Heyland D.K., Drover J.W., Dhaliwal R., Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. JPEN J Parenter Enteral Nutr. 26:2002;S51-S55.
48. Heyland D.K., Cook D.J., Schoenfeld P.S., Frietag A., Varon J., Wood G. The effect of acidified enteral feeds on gastric colonization in critically ill patients: results of a multicenter randomized trial. Crit Care Med. 27:1999;2399-2406.
49. Zaloga G.P. Immune-enhancing enteral diets: Where's the beef? Crit Care Med. 26:1998;1143-1146.
50. Atkinson S., Sieffert E., Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Crit Care Med. 26:1998;1164-1172.
51. Houdijk A.P.J., Rijnsburger E.R., Jansen J., et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 352:1998;772-776.
52. Valles J., Artigas A., Rello J., et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med. 122:1995;179-186.
53. Mahul P., Auboyer C., Jospe R., et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med. 18:1992;20-25.
54. Kollef M.H., Skubas N.J., Sundt T.M. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest. 116:1999;1339-1346.
55. Smulders K., van der Hoeven H., Weers-Pothoff I., Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest. 121:2002;858-862.
56. Torres A., Serra-Batlles J., Ros E., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 116:1992;540-543.
57. Drakulovic M.B., Torres A., Bauer T.T., Nicolas J.M., Nogué S., Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 354:1999;1851-1858.